UPNEEQ®

Description

Have you noticed a change in the appearance of your eyes, where your lids are starting to droop? You may have acquired ptosis, or low-lying lids.

Acquired ptosis (low-lying lids) is a common medical condition that:
Affects adults of all ages, but occurs more often with increased age.
Usually occurs when the muscles in the eyelid stretch and weaken, causing the upper eyelid to droop and causing asymmetrical eyes.
May be caused by other issues, such as cataract surgery, contact lens wear, or an underlying medical condition. It could also be a sign of a more serious medical condition.

In clinical trials, Upneeq® helped patients with acquired ptosis see more—on the first day of treatment!
87% of patients had some form of improvement.

74% of patients had at least a 50% improvement on Day 14 (2 hours after applying Upneeq®).

UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1 % contains oxymetazoline hydrochloride, an alpha adrenoceptor agonist and is FDA approved for the treatment of acquired blepharoptosis (low-lying eyelids) in adults. Acquired ptosis can develop later in life and usually occurs when muscles in the eyelid stretch and weaken, causing the lid to droop. Eyelid ptosis may be caused by other issues, such as cataract surgery, contact lens wear, or an underlying medical condition. Eyelid ptosis can affect eyesight by not only blocking your vision, but also by reducing field of vision

Please note, Upneeq® is a prescription product. Uploading the required photos or a telemedicine consultation is required to see if you are a good candidate for this medication. If you are not deemed a good candidate, a refund will be issued.

Each prescription contains 45, 0.3 mL single use applicators in individual child-resistant foil pouches.

TSA Friendly: Yes